Urotensin-II Receptor – autophagy inhibitors for cancer chemotherapeutics

Latest Post

Kashefi-Kheyrabadi et al There was no clear suppression of normal immunoglobulins and only mild lymphopenia in 1 patient, suggesting adequate systemic immune competency at time of glioblastoma diagnosis

Mouse anti-Myc antibody M-5546 was from Sigma, infrared fluorescence dye IRDye680-labeled goat anti-mouse antibody and IRDye 800CW-streptavidin were from LI-COR Biosciences

On December 8, 2025 By mergullo

Urotensin-II Receptor

Mouse anti-Myc antibody M-5546 was from Sigma, infrared fluorescence dyeRead More

The BT50, was thought as the serum dilution of which the OD450value was 50% of this from the positive control (VLPs only)

On June 20, 2025 By mergullo

Urotensin-II Receptor

The BT50, was thought as the serum dilution of whichRead More

The vessels of the islets were weakly positive for intercellular adhesion molecule 1 (ICAM-1), strongly positive for platelet endothelial cell adhesion molecule 1 (PECAM-1), and negative for vascular cell adhesion molecule-1 and P-selectin (13)

On March 27, 2023 By mergullo

Urotensin-II Receptor

The vessels of the islets were weakly positive for intercellularRead More

Let denote the output of the GNN for a given sequence with respect to the network weights

On December 4, 2022 By mergullo

Urotensin-II Receptor

Let denote the output of the GNN for a givenRead More

Positive staining for ER- in the nuclei of endometrial glandular cells (g, h, and we) through the proliferative phase and vulnerable or harmful staining for ER- in the nuclei of endometrial glandular cells (j, k, and l) through the secretory phase

On February 16, 2022 By mergullo

Urotensin-II Receptor

Positive staining for ER- in the nuclei of endometrial glandularRead More